These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 33000310)
1. Deletion of a decoy epitope in porcine circovirus 2 (PCV2) capsid protein affects the protective immune response in mice. Kim K; Shin M; Hahn TW Arch Virol; 2020 Dec; 165(12):2829-2835. PubMed ID: 33000310 [TBL] [Abstract][Full Text] [Related]
2. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice. Jung BK; Kim HR; Jang H; Chang KS J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038 [TBL] [Abstract][Full Text] [Related]
3. Porcine circovirus type 2 protective epitope densely carried by chimeric papaya ringspot virus-like particles expressed in Escherichia coli as a cost-effective vaccine manufacture alternative. Aguilera BE; Chávez-Calvillo G; Elizondo-Quiroga D; Jimenez-García MN; Carrillo-Tripp M; Silva-Rosales L; Hernández-Gutiérrez R; Gutiérrez-Ortega A Biotechnol Appl Biochem; 2017 May; 64(3):406-414. PubMed ID: 26970530 [TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae. Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377 [TBL] [Abstract][Full Text] [Related]
5. Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope. Mo X; Li X; Yin B; Deng J; Tian K; Yuan A PLoS Pathog; 2019 Mar; 15(3):e1007562. PubMed ID: 30822338 [TBL] [Abstract][Full Text] [Related]
6. Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2. Huang LP; Lu YH; Wei YW; Guo LJ; Liu CM BMC Microbiol; 2011 Aug; 11():188. PubMed ID: 21859462 [TBL] [Abstract][Full Text] [Related]
7. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B. Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366 [TBL] [Abstract][Full Text] [Related]
8. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782 [TBL] [Abstract][Full Text] [Related]
9. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2. Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758 [TBL] [Abstract][Full Text] [Related]
10. A recombinant porcine circovirus type 2 expressing the VP1 epitope of the type O foot-and-mouth disease virus is infectious and induce both PCV2 and VP1 epitope antibodies. Huang L; Zhang F; Tang Q; Wei Y; Wu H; Guo L; Fu Y; Liu C Appl Microbiol Biotechnol; 2014 Nov; 98(22):9339-50. PubMed ID: 25117547 [TBL] [Abstract][Full Text] [Related]
11. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli. Wu PC; Chen TY; Chi JN; Chien MS; Huang C J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354 [TBL] [Abstract][Full Text] [Related]
12. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation. Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments. Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139 [TBL] [Abstract][Full Text] [Related]
14. Construction and biological characterisation of recombinant porcine circovirus type 2 expressing the V5 epitope tag. Huang L; Lu Y; Wei Y; Guo L; Wu H; Zhang F; Fu Y; Liu C Virus Res; 2011 Nov; 161(2):115-23. PubMed ID: 21641944 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice. Jung BK; Kim HR; Lee YH; Jang H; Chang KS J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882 [TBL] [Abstract][Full Text] [Related]
16. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets. Zhang H; Qian P; Peng B; Shi L; Chen H; Li X Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115 [TBL] [Abstract][Full Text] [Related]
17. Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice. Fan H; Pan Y; Fang L; Wang D; Wang S; Jiang Y; Chen H; Xiao S J Virol Methods; 2008 Jun; 150(1-2):21-6. PubMed ID: 18394722 [TBL] [Abstract][Full Text] [Related]
18. Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine. Yu C; Li X; Liu J; Diao W; Zhang L; Xiao Y; Wei H; Yu Y; Yu Y; Wang L Vaccine; 2016 Dec; 34(50):6358-6366. PubMed ID: 27817956 [TBL] [Abstract][Full Text] [Related]
19. Early antibody responses map to non-protective, PCV2 capsid protein epitopes. Ilha M; Nara P; Ramamoorthy S Virology; 2020 Jan; 540():23-29. PubMed ID: 31734380 [TBL] [Abstract][Full Text] [Related]
20. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]